Treatment Study of AV Node Reentry Tachycardia
Status unconfirmed · Not applicable
Conditions studied: Supraventricular Tachycardia
In brief
Compare the effectiveness and safety of two techniques for modification of slow AV nodal pathway conduction underlying AVNRT: 1) New Ablation Technique, low voltage and wave front collision mapping vs. 2) the Standard Ablation Technique, an anatomical/electrogram approach.
Key facts
- Study ID
- NCT04232371
- Run by
- Jeffrey Moak
- People needed
- 300
- Starts
- 2020-07-15
- Expected to finish
- 2023-03-01
- Last updated by the study team
- 2022-07-28
Who can join
Age: any, up to 21. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Weight >15 kg
- Age < 21 years old
- Simple CHD acceptable to enroll (Table 1):
- Table 1. Diagnoses in Adult Patients with Simple Congenital Heart Disease
- Isolated congenital aortic valve disease
- Isolated congenital mitral valve disease (eg, except parachute valve, cleft leaflet)
- Small atrial septal defect
- Isolated small ventricular septal defect (no associated lesions)
- Mild pulmonary stenosis
- Small patent ductus arteriosus
- Repaired conditions
- Previously ligated or occluded ductus arteriosus
- Repaired secundum or sinus venosus atrial septal defect without residua
- Repaired ventricular septal defect without residua
You may not qualify if…
- Additional mechanism(s) for SVT in addition to AV nodal reentry tachycardia.
- Moderate or Complex Congenital Heart Disease, see tables 2 and 3.
- Table 2. Diagnoses in Adult Patients with Congenital Heart Disease of Moderate Complexity
- Aorto-left ventricular fistulas
- Anomalous pulmonary venous drainage, partial or total
- Atrioventricular septal defects (partial or complete)
- Coarctation of the aorta
- Ebstein's anomaly
- Infundibular right ventricular outflow obstruction of significance
- Ostium primum atrial septal defect
- Patent ductus arteriosus (not closed)
- Pulmonary valve regurgitation (moderate to severe)
- Pulmonary valve stenosis (moderate to severe)
- Sinus of Valsalva fistula/aneurysm
- Sinus venosus atrial septal defect
- Subvalvular AS or SupraAS (except HOCM)
- Tetralogy of Fallot
- Ventricular septal defect with:
- Absent valve or valves
- Aortic regurgitation
- Coarctation of the aorta
- Mitral disease
- Right ventricular outflow tract obstruction
- Straddling tricuspid/mitral valve
- Subaortic stenosis
Where it is running
- Children's National Hospital — Washington D.C., District of Columbia, United States (enrolling)
- Memorial Health System — Hollywood, Florida, United States (enrolling)
- Univeristy of Iowa — Iowa City, Iowa, United States (enrolling)
- University of Louisville — Louisville, Kentucky, United States (enrolling)
- University of Wisconsin — Madison, Wisconsin, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.